UCSF Department of Psychiatry and Behavioral Sciences
@ucsfpsych.bsky.social did:plc:td37ll5g4w6nscd22lclr3mt
We are committed to advancing mental health across the lifespan with a mission focused on research, teaching, patient care and public service. linktr.ee/ucsfpsychiatry Social Media Disclaimer: https://psychiatry.ucsf.edu/connect
Bluesky’a katılma tarihi:
- Takipçi
- 231
- Takip edilen
- 48
- Post
- 468
- Sıralamaya girdiği gün
- 0
Özet
UCSF Department of Psychiatry and Behavioral Sciences (@ucsfpsych.bsky.social), 21 Kasım 2024 tarihinde katılan bir Bluesky kullanıcısı. 231 takipçisi var, 48 hesabı takip ediyor ve 468 post paylaştı.
Sıralama geçmişi
Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.
Bu hesap henüz günlük sıralamaya girmedi.
Son beğendiği postlar
Bluesky ağındaki herkese açık beğeniler.
🗣️ New @ucsfchildrens.bsky.social study in Pediatrics! Following 11,279 adolescents over 5 years, we found: 🔄 Problematic social media use & depression may reinforce each other 👧 The link was stronger among girls 🔗 tinyurl.com/DepSM26 @ameracadpeds.bsky.social
Postu göster📱 What does the evidence show about policies to protect teens on social media? New in @jamanetworkopen.com: We reviewed 39 publications across 6 policy approaches. 🔗https://tinyurl.com/SMPolicy26
Postu göster🗣️ New @ucsfchildrens.bsky.social study in @ajpmonline.bsky.social! 🧠Adolescents in the low-to-moderate and moderate-to-high problematic social media use trajectories had lower cognitive performance 🔗 Read here: tinyurl.com/socmind @theabcdstudy.bsky.social
Postu göster🗣️ New @ucsfchildrens.bsky.social study in @annalsofepi.bsky.social! Among 10,735 adolescents in @theabcdstudy.bsky.social, we found that adolescents with increasing social media use are more likely to experience greater eating disorder symptoms. 🔗 Read here: tinyurl.com/EDTraj
Postu gösterLed by Adam Boxer, MD, PhD, and colleagues, UCSF is screening participants for the Alzheimer's Tau Platform (ATP) trial, the first large-scale national study to test combination therapy targeting both amyloid and tau in early or asymptomatic Alzheimer's disease.
Postu göster
Blokladığı hesaplar
Bluesky’da bloklar herkese açık kayıtlardır.
